National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/8/2021 release of VAERS data:

This is VAERS ID 1045498

Case Details

VAERS ID: 1045498 (history)  
Form: Version 2.0  
Sex: Female  
Location: Foreign  
   Days after vaccination:31
Submitted: 0000-00-00
Entered: 2021-02-22
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: ?
Symptoms: Body temperature, Dyspnoea, Fatigue, Pyrexia
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-01
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: ADHD; Asperger''s disorder; Chronic obstructive pulmonary disease; Congenital oesophageal anomaly; Hepatitis C; Pulmonary fibrosis; Respiratory congenital anomaly; Right ventricular failure
Diagnostic Lab Data: Test Name: temperature; Result Unstructured Data: Test Result:38 degrees
CDC Split Type: SEPFIZER INC2021158460

Write-up: Breathing difficult; Fever; tiredness; This is a spontaneous report from a contactable nurse downloaded from the Regulatory Authority, Regulatory Authority number SE-MPA-2021-003068. Other case identifier number SE-MPA-1612791403816. A 47-year-old female patient received the first dose of bnt162b2 (COMIRNATY) (Batch/lot number: EJ6134) intramuscularly in Jan2021 at 0.3ml single for COVID-19 immunisation. Medical history included congenital oesophageal anomaly, respiratory congenital anomaly, chronic obstructive pulmonary disease, pulmonary fibrosis, attention deficit hyperactivity disorder (ADHD), Asperger''s disorder, hepatitis C, right ventricular failure, all unknown if ongoing. Concomitant medications were not reported (Current medication list was missing). Patient developed fever and breathing difficult in Feb2021. According to the reporting nurse the woman (patient), five days after the vaccination with Comirnaty, developed tiredness, fever (38 degrees) and difficulty breathing in Feb2021. The woman herself called an ambulance, she was given Alvedon and Ventoline and booked an appointment at the health center the following day. The next morning, the woman was found dead on the floor of her home (Feb2021). It was not reported if an autopsy was performed. Report assessed the events as serious, Death.; Reported Cause(s) of Death: Breathing difficult; Fever; tiredness

New Search

Link To This Search Result:

Government Disclaimer on use of this data

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166